Australia - English - Department of Health (Therapeutic Goods Administration)

viiv healthcare pty ltd - abacavir sulfate, quantity: 351 mg (equivalent: abacavir, qty 300 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate; magnesium stearate; colloidal anhydrous silica; titanium dioxide; hypromellose; polysorbate 80; iron oxide yellow; triacetin - ziagen (abacavir) is indicated in antiretroviral combination therapy for the treatment of human immunodeficiency virus (hiv) infection in adults and children (see clinical trials). this indication is based on surrogate endpoints in studies up to 48 weeks in duration.

United States - English - NLM (National Library of Medicine)

burel pharmaceuticals, llc - abacavir sulfate (unii: j220t4j9q2) (abacavir - unii:wr2tip26vs), lamivudine (unii: 2t8q726o95) (lamivudine - unii:2t8q726o95) - abacavir and lamivudine tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus type 1 (hiv-1) infection. abacavir and lamivudine tablets are contraindicated in patients: • who have the hla-b*5701 allele [see warnings and precautions (5.1)]. • with prior hypersensitivity reaction to abacavir [see warnings and precautions (5.1)] or lamivudine. • with moderate or severe hepatic impairment [see use in specific populations (8.7)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to abacavir and lamivudine during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr) at 1-800-258-4263. risk summary available data from the apr show no difference in the overall risk of birth defects for abacavir or lamivudine compared with the background rate for birth defects of 2.7% in the metropolitan atl

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

cipla quality chemical industries limited, uganda - dolutegravir sodium, lamivudine , tenofovovir disoproxil fumarate - tablets

Kenya - English - Pharmacy and Poisons Board

cipla limited cipla house, peninsula business park, ganpatrao - abacavir sulfate usp lamivudine usp - dispersible tablet - abacavir sulfate- 120mg lamivudine- 60 mg - lamivudine and abacavir

Kenya - English - Pharmacy and Poisons Board

mylan laboratories limited c/o. surgilinks ltd mylan laboratories limited, plot no.564/a/22, - abacavir sulfate and lamivudine - film-coated tablet - abacavir sulfate 600mg / lamivudine 300mg - lamivudine and abacavir

Kenya - English - Pharmacy and Poisons Board

abacavir sulfate and lamivudine tablets for oral… - tablet for oral suspension - abacavir sulfate usp equivalent to abacavir… - lamivudine and abacavir

Kenya - English - Pharmacy and Poisons Board

aurobindo pharma ltd aurobindo - abacavir sulfate usp and lamivudine usp - film-coated tablet - abacavir sulfate 600 mg and lamivudine 300 mg - lamivudine and abacavir

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viiv healthcare uk ltd - lamivudine; dolutegravir sodium; abacavir sulfate - tablet - 300mg ; 50mg ; 600mg

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - abacavir, lamivudine - film-coated tablet - abacavir 600 mg lamivudine 300 mg - antivirals for systemic use

Malta - English - Medicines Authority

teva b.v. swensweg 5, 2031 ga haarlem, netherlands - abacavir, lamivudine - film-coated tablet - abacavir 600 mg lamivudine 300 mg - antivirals for systemic use